Patent · US Active

Aromatic farnesyl compound and application thereof

US10441562B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

Institute of Microbiology Chinese Academy of Sciences · CN

Inventors

Hongwei Liu · San Diego, US
Kai Wang · Longbeilingcun, CN
Li Bao · Yuki, JP
Junjie Han · Beijing, CN

Key dates

Filing date	Dec 18, 2015
Grant date	Oct 15, 2019
Priority date	—
Expiry date	Dec 18, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2300/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aromatic farnesyl compound and application of a pharmaceutical salt thereof as an inhibitor of α-glucosidase, dipeptidyl peptidase-4, aldose reductase, protein tyrosine phosphatase-1B or HMG-CoA reductase, or use thereof in preparing medicine and functional healthcare products having a liver protective function and/or for treating and/or preventing type II diabetes, diabetic retinopathy, diabetic foot disease, and hyperlipidemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.